CRDF

CRDF R&D Expenses

$25.95MTTM · USD

Period ending:

CRDF FY R&D ExpensesUSD
CRDF FY R&D Expenses2005-01-31: $619.64K2006-01-31: $1.88M2009-12-31: $0.002010-12-31: $3.69M2011-12-31: $910.69K2012-12-31: $1.92M2013-12-31: $3.95M2014-12-31: $6.67M2015-12-31: $10.59M2016-12-31: $15.01M2017-12-31: $7.88M2018-12-31: $8.16M2019-12-31: $11.16M2020-12-31: $11.24M2021-12-31: $17.38M2022-12-31: $27.11M2023-12-31: $32.86M2024-12-31: $36.85M2025-12-31: $35.33M$36.85M$0.00
2005-01-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CRDF r&d expenses history

Research and development spending. The available annual fiscal periods series contains 19 observations from Jan 31, 2005 to Dec 31, 2025.

Cardiff Oncology Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
35,329,000
36,852,000
32,857,000
27,107,000
17,376,000
11,235,000
11,162,236
8,164,000
7,883,000
15,007,000
10,594,000
6,665,000
3,947,589
1,920,000
910,685
3,691,028
0
1,878,081
619,635

Compare r&d expenses

All CRDF financial metrics · CRDF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.